Clinical Trial Update: A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy [Phase 3]

View source ↗

Summary

Phase III trial update for HRS-1893 in obstructive hypertrophic cardiomyopathy is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• HRS-1893

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Obstructive Hypertrophic Cardiomyopathy | Phase 3 | Status: ACTIVE_NOT_RECRUITING